400客服电话
购买数据产品
400-9696-311 转1
定制咨询业务
400-9696-311 转2
数据与AI定制业务
400-9696-311 转3
商务合作及其他问题
400-9696-311 转4
投诉及建议
400-9696-311 转5
ChiCTR2400090027
尚未开始
/
/
/
2024-09-23
/
/
breast cancer
Self compassion, post-traumatic growth and body image of women with breast cancer
Body image and post-traumatic growth in women with breast cancer: self compassion as mediator and intervention
Hypothesis 1: Body image distress is inversely related to self-compassion and positively related to psychological distress Hypothesis 2: Self-compassion is positively related to post-traumatic growth Hypothesis 3: Self-compassion mediates the relationship between body image and posttraumatic growth. Hypothesis 4: Women with breast cancer assigned the self-compassion intervention group will report increased self-compassion, reduced body image distress, increased post traumatic growth, reduced psychological distress compared to the control group. reduced psychological distress compared to the control group.
随机平行对照
探索性研究/预试验
Random number table
Not stated
None
/
54;131
/
2024-10-01
2025-09-30
/
Inclusion criteria for both study 1 and study 2 include being 18 years old or older, identifying as a woman, ability to read Chinese and understand Cantonese, first-time clinical diagnosis of stage I-III breast malignancies, and being in the medical treatment phase for cancer. Additional inclusion criteria for study 2 include access to the internet, willingness to attend all the group sessions, experiencing body image distress (i.e. self-reported Body Image Scale (BSI) score >= 10).；
请登录查看For both study 1 and study 2, individuals with other types of primary cancers will be excluded. Additional exclusion criteria for study 2 include past or current involvement in self-compassion intervention, regular practice of meditation in the past 6 months, cognitive impairment, and history of serious mental health disorders such as bipolar disorder and schizophrenia-spectrum disorders.；
请登录查看The University of Hong Kong
/
德琪医药2026-07-20
动脉网-最新2026-07-20
药精通Bio2026-07-20
求实药社2026-07-20
求实药社2026-07-20
康方生物Akeso2026-07-20
干细胞与外泌体2026-07-20
加科思2026-07-20
良医汇肿瘤资讯2026-07-19
GLP1减重宝典2026-07-19
400-9696-311 转1
400-9696-311 转3
400-9696-311 转4
400-9696-311 转5
川公网安备51019002008863号
本网站未发布麻醉药品、精神药品、医疗用毒性药品、放射性药品、戒毒药品和医疗机构制剂的产品信息
“坚决打赢禁毒人民战争”专栏 法律法规 | 美、墨、欧盟管制品种
友情链接: 摩熵医药 摩熵医药企业版 摩熵化学MolAid 晓材Matmole 摩熵医学MedXYZ 载体质粒 觅健肿瘤互助 动脉网 药物百科 中国医疗人才网 医药招商网
